Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Phenylpiracetam is a synthetic derivative of the racetam class of nootropics, originally developed in Russia. There is some scientific evidence suggesting that phenylpiracetam can influence the dopamine system, particularly in animal studies and limited human trials. Preclinical research indicates that phenylpiracetam may increase dopamine receptor density and enhance dopamine-mediated neurotransmission, which could underlie its reported effects on mood, motivation, and cognitive function (Akhmedova et al., 2001). Some human studies from Russia have reported improvements in physical performance and tolerance to stress, effects that may be partially attributed to dopaminergic activity, but these studies are small and often not published in English-language peer-reviewed journals.

Despite these findings, the overall clinical evidence in humans is limited, with few rigorous, large-scale trials directly linking phenylpiracetam to significant support of the dopamine system. The available data suggest possible effects but fall short of definitive proof. Thus, while there is a scientific rationale for its use to support dopamine-related functions, the evidence base is not robust, and more research is needed to confirm efficacy and safety in this context.

More about phenylpiracetam
More about Dopamine

Other ingredients that support Dopamine

Other body systems supported by phenylpiracetam

Products containing phenylpiracetam